CIt’s a sound we take for granted: that of breathing. Silent, continuous, invisible. But when it breaks, it reminds us how fragile we are. There pneumoniawhich affects more than 150 million people worldwide every year, remains one of the main preventable causes of death, especially among children, the elderly and frail people. On the occasion of World Pneumonia Day 2026science sends a clear message: it is not a pathology “of the past”, but a current challenge, which is fought with research, vaccines, and daily awareness. From the new generation vaccine to rapid tests, here are the seven weapons that science makes available to us to defend the breath.
Here they are seven most important news according to the latest scientific evidence.
1. New generation vaccines: broader and longer-lasting protection
The new anti-pneumococcal formulations – PCV15, PCV20 and PCV21 – offer broader coverage and longer protection against the main strains of Streptococcus pneumoniae.
According to a review published on Vaccines in 2025, these releases “have reshaped adult immunization strategies” and reduced the need for booster shots (MDPI Vaccines, 2025).
In parallel, an international trial underway in Melbourne is testing a 21-valent vaccine intended for newborns, with encouraging results (Murdoch Children’s Research Institute, 2025).
For whom: children, elderly people, people with chronic pathologies and immunocompromised remain the priority categories.
2. When to get the vaccine (and why not postpone it)
The pneumococcal vaccine is recommended for children within the second year of life and for adults above i 65 years old or with respiratory and cardiovascular diseases.
According to the National Foundation for Infectious Diseasesvaccination campaigns have reduced hospitalizations for pneumonia among those over 65 by up to 75% (NFID, 2025).
Practical tip: it is a good idea to ask your GP or pediatrician to include the pneumococcal vaccination in your annual vaccination plan, together with the flu vaccine.
3. Early diagnosis: the era of rapid tests arrives
Recognizing pneumonia early can save your life. They are available today point-of-care diagnostic testscapable of identifying the pathogen in just a few minutes.
Published studies on the topic indicate that urinary antigen tests for pneumococcal pneumonia can improve etiological diagnosis and contribute to the targeted use of antibiotics (for example: S. Yasuo et al., Diagnostic accuracy of urinary antigen tests for S. pneumoniae2022).
Practical tip: high fever, persistent cough and shortness of breath should not be underestimated. Today the diagnosis is simpler, but timeliness remains crucial.
4. New treatments and precision antibiotics
The overuse of antibiotics has made it more difficult to fight bacterial pneumonia. A review published on The Lancet EClinical Medicine highlighted theincrease in resistant strains, especially in adults over 50 (The Lancet, 2022). The 2026 guidelines propose a personalized therapybased on genetic tests that identify the pathogen and predict response to the antibiotic.
In parallel, new antivirals are in development for post-Covid viral pneumonias.
5. Lifestyle and environment: stronger lungs, lower risk
Observational studies indicate that quitting smoking significantly reduces the risk of pneumonia and pneumonia-related mortality: for example, after 10-15 years of abstinence the risk can be reduced by up to 40-50% compared to those who continue to smoke. The literature suggests that factors such as pollution, a sedentary lifestyle, and a low-fiber diet contribute to vulnerability to respiratory infections, although exact estimates vary by study (PubMed).
Protecting your lungs means: avoid smoking and indoor pollution; take care of nutrition; maintain a balanced weight and good physical activity.
6. Who is most at risk today
Not just children and the elderly. The latest research identifies new vulnerable categories. Scientific evidence indicates that conditions such as obesity, pregnancy or autoimmune diseases are associated with greater vulnerability to respiratory infections, even severe ones, due to alterations in the immune system. For example, studies on Frontiers in Immunology show that obesity is related to altered innate responses in the context of viral infections.
It’s a good idea to talk to your doctor about it: in many cases vaccination can be included in the personalized treatment plan.
7. Microbiota and lungs: an invisible but powerful link
Recent studies indicate that alteration of the microbiota (intestinal or pulmonary) is associated with increased vulnerability to respiratory infections, including severe cases in the pulmonary tract. For example, research published on Nature Communications in 2024 found that in patients with respiratory failure, low lung microbiota diversity was correlated with worse outcomes.
How to act: promote a balanced microbiota – for example through a diet rich in fibre, vegetables and wholemeal and a healthy lifestyle – can be considered a useful strategy to support respiratory health.